Lenz Therapeutics Stock Price Patterns
| LENZ Stock | 12.88 0.09 0.69% |
Momentum 37
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.80) | EPS Estimate Current Year (2.58) | EPS Estimate Next Year (3.03) | Wall Street Target Price 51.2857 | EPS Estimate Current Quarter (0.69) |
Using LENZ Therapeutics hype-based prediction, you can estimate the value of LENZ Therapeutics from the perspective of LENZ Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards LENZ Therapeutics using LENZ Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards LENZ using crowd psychology based on the activity and movement of LENZ Therapeutics' stock price.
LENZ Therapeutics Short Interest
An investor who is long LENZ Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about LENZ Therapeutics and may potentially protect profits, hedge LENZ Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 29.7869 | Short Percent 0.3996 | Short Ratio 6.01 | Shares Short Prior Month 8.7 M | 50 Day MA 18.694 |
LENZ Therapeutics Hype to Price Pattern
Investor biases related to LENZ Therapeutics' public news can be used to forecast risks associated with an investment in LENZ. The trend in average sentiment can be used to explain how an investor holding LENZ can time the market purely based on public headlines and social activities around LENZ Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of LENZ Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about LENZ Therapeutics.
LENZ Therapeutics Implied Volatility | 1.81 |
LENZ Therapeutics' implied volatility exposes the market's sentiment of LENZ Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if LENZ Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that LENZ Therapeutics stock will not fluctuate a lot when LENZ Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in LENZ Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying LENZ because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
LENZ Therapeutics after-hype prediction price | USD 13.82 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current LENZ contract
Based on the Rule 16, the options market is currently suggesting that LENZ Therapeutics will have an average daily up or down price movement of about 0.11% per day over the life of the 2026-04-17 option contract. With LENZ Therapeutics trading at USD 12.88, that is roughly USD 0.0146 . If you think that the market is fully incorporating LENZ Therapeutics' daily price movement you should consider acquiring LENZ Therapeutics options at the current volatility level of 1.81%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out LENZ Therapeutics Basic Forecasting Models to cross-verify your projections. LENZ Therapeutics After-Hype Price Density Analysis
As far as predicting the price of LENZ Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in LENZ Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of LENZ Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
LENZ Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting LENZ Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on LENZ Therapeutics' historical news coverage. LENZ Therapeutics' after-hype downside and upside margins for the prediction period are 8.28 and 19.36, respectively. We have considered LENZ Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
LENZ Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of LENZ Therapeutics is based on 3 months time horizon.
LENZ Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as LENZ Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading LENZ Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with LENZ Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.96 | 5.54 | 0.94 | 0.53 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
12.88 | 13.82 | 7.30 |
|
LENZ Therapeutics Hype Timeline
LENZ Therapeutics is now traded for 12.88. The entity has historical hype elasticity of 0.94, and average elasticity to hype of competition of -0.53. LENZ is estimated to increase in value after the next headline, with the price projected to jump to 13.82 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 7.3%, whereas the daily expected return is now at -0.96%. The volatility of related hype on LENZ Therapeutics is about 1012.8%, with the expected price after the next announcement by competition of 12.35. Given the investment horizon of 90 days the next estimated press release will be in about 9 days. Check out LENZ Therapeutics Basic Forecasting Models to cross-verify your projections.LENZ Therapeutics Related Hype Analysis
Having access to credible news sources related to LENZ Therapeutics' direct competition is more important than ever and may enhance your ability to predict LENZ Therapeutics' future price movements. Getting to know how LENZ Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how LENZ Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GHRS | GH Research PLC | (3.36) | 9 per month | 4.40 | 0.04 | 6.76 | (8.53) | 40.50 | |
| SPRY | ARS Pharmaceuticals | (0.52) | 8 per month | 4.34 | 0.01 | 8.29 | (7.26) | 32.13 | |
| NBTX | Nanobiotix | (0.71) | 27 per month | 3.50 | 0.05 | 6.58 | (5.91) | 21.79 | |
| MRVI | Maravai Lifesciences Holdings | (0.20) | 8 per month | 3.57 | 0.02 | 8.38 | (6.35) | 22.00 | |
| RZLT | Rezolute | 0.24 | 8 per month | 15.07 | 0.03 | 18.05 | (9.22) | 98.27 | |
| GERN | Geron | 0.04 | 9 per month | 2.57 | 0.15 | 6.72 | (3.70) | 16.99 | |
| TYRA | Tyra Biosciences | (0.46) | 10 per month | 2.01 | 0.22 | 6.05 | (4.26) | 34.11 | |
| SVRA | Savara Inc | (0.09) | 8 per month | 3.20 | 0.12 | 8.43 | (5.30) | 24.50 | |
| PRME | Prime Medicine Common | (0.25) | 9 per month | 4.66 | (0) | 11.05 | (8.19) | 25.37 | |
| ABUS | Arbutus Biopharma Corp | (0.16) | 6 per month | 0.00 | (0.06) | 5.47 | (5.79) | 20.16 |
LENZ Therapeutics Additional Predictive Modules
Most predictive techniques to examine LENZ price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for LENZ using various technical indicators. When you analyze LENZ charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About LENZ Therapeutics Predictive Indicators
The successful prediction of LENZ Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as LENZ Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of LENZ Therapeutics based on analysis of LENZ Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to LENZ Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to LENZ Therapeutics's related companies. | 2010 | 2025 | 2026 (projected) | Dividend Yield | 0.5 | 0.45 | 0.4 | Price To Sales Ratio | 8.21 | 7.39 | 6.57 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LENZ Stock Analysis
When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.